These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2680026)

  • 1. Neuropathological and neuropsychological changes in Alzheimer's disease. Relationship of biologic markers to behavioral markers.
    Pirozzolo FJ; Inbody SB; Sims PA; Strittmatter WJ; Baskin D
    Clin Geriatr Med; 1989 Aug; 5(3):425-40. PubMed ID: 2680026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early diagnosis of Alzheimer disease].
    Touchon J; Ritchie K; Gely-Nargeot MC
    Ann Med Interne (Paris); 1998 Jun; 149(4):193-201. PubMed ID: 11490546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of Alzheimer's disease].
    Delacourte A
    Ann Biol Clin (Paris); 1998; 56(2):133-42. PubMed ID: 9754238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prodromal Alzheimer's disease.
    Mortimer JA; Petersen RC
    Ann Neurol; 2008 Nov; 64(5):479-80. PubMed ID: 19067352
    [No Abstract]   [Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease as a cause of death in the United States.
    Hoyert DL; Rosenberg HM
    Public Health Rep; 1997; 112(6):497-505. PubMed ID: 10822478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Alzheimer's disease--an update.
    Srinivas P
    Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should we revise the Alzheimer's disease diagnostic criteria?].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2008 Mar; 6(1):81-2. PubMed ID: 18441609
    [No Abstract]   [Full Text] [Related]  

  • 10. Implicit memory and Alzheimer's disease neuropathology.
    Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
    Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease.
    Zamrini E; De Santi S; Tolar M
    Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From senility to Alzheimer's disease: the rise of the Alzheimer's disease movement.
    Fox P
    Milbank Q; 1989; 67(1):58-102. PubMed ID: 2682166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests.
    Farias ST; Harrell E; Neumann C; Houtz A
    Arch Clin Neuropsychol; 2003 Aug; 18(6):655-72. PubMed ID: 14591439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N; Ahmed U; Thornalley PJ; Hager K; Fleischer G; Münch G
    J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease.
    Thomas P; Hecker J; Faunt J; Fenech M
    Mutagenesis; 2007 Nov; 22(6):371-9. PubMed ID: 17709794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.
    Visser PJ; Vos S; van Rossum I; Scheltens P
    Alzheimers Dement; 2012 Nov; 8(6):560-3. PubMed ID: 23102126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
    Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
    Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
    Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
    Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.